Can Helicobacter pylori (H. pylori) infection be treated during pregnancy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 20, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

H. pylori infection should not be treated during pregnancy unless absolutely necessary, due to the potential risks to the fetus and the lack of strong evidence supporting the safety and efficacy of treatment during this period. The management of H. pylori infection is complex and requires careful consideration, as outlined in the Maastricht Consensus Report 1. While the report recommends eradication therapy for H. pylori positive patients with peptic ulcer disease, it does not specifically address treatment during pregnancy. Some key points to consider when deciding whether to treat H. pylori during pregnancy include:

  • The potential risks to the fetus associated with certain medications, such as clarithromycin and tetracycline
  • The effectiveness of alternative treatments, such as lifestyle changes and antacids, in managing mild symptoms
  • The importance of consulting with an obstetrician before starting any treatment during pregnancy In general, treatment during pregnancy is typically only recommended if the benefits outweigh the potential risks, such as in cases of severe symptoms or complications. The recommended treatment regimen, if necessary, would likely involve medications that are considered safe during pregnancy, such as amoxicillin and metronidazole, in combination with a proton pump inhibitor like omeprazole, as suggested by the Maastricht Consensus Report 1. However, the specific treatment approach would depend on the individual patient's situation and should be determined in consultation with a healthcare provider. It's also important to note that the Maastricht Consensus Report 1 is an older study, and more recent guidelines may be available, but it provides a foundation for understanding the complexities of H. pylori management.

From the Research

Treatment of H. pylori Infection During Pregnancy

  • H. pylori infection can be treated during pregnancy, but the choice of therapy is crucial due to potential contraindications to certain antibiotics 2.
  • First-line therapy for H. pylori infection includes clarithromycin triple therapy, bismuth quadruple therapy, or concomitant therapy, but the selection of therapy may be challenging due to concerns for potential resistance to agents included in the initial regimen 2.
  • The treatment of H. pylori infection during pregnancy should be guided by the patient's specific situation and the local resistance pattern 3.

Considerations for Treatment During Pregnancy

  • The safety of H. pylori treatment during pregnancy is a concern, and the choice of therapy should be made carefully to minimize potential risks to the mother and the fetus 2.
  • The use of certain antibiotics, such as clarithromycin, during pregnancy may be limited due to potential risks of resistance and side effects 4.
  • Alternative treatment regimens, such as bismuth quadruple therapy or concomitant therapy, may be considered for pregnant women with H. pylori infection 2, 3.

Available Treatment Options

  • Clarithromycin triple therapy, which includes clarithromycin, a proton pump inhibitor, and amoxicillin or metronidazole, is a commonly used first-line treatment for H. pylori infection 2, 4.
  • Bismuth quadruple therapy, which includes bismuth salt, a proton pump inhibitor, tetracycline, and metronidazole or amoxicillin, is an alternative first-line treatment option 2, 5.
  • Concomitant therapy, which includes clarithromycin, a proton pump inhibitor, amoxicillin, and metronidazole, is another first-line treatment option for H. pylori infection 2.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Current options for the treatment of Helicobacter pylori.

Expert opinion on pharmacotherapy, 2013

Research

Clarithromycin for Helicobacter pylori infection.

Expert opinion on pharmacotherapy, 2000

Research

'Rescue' therapies for the management of Helicobacter pylori infection.

Digestive diseases (Basel, Switzerland), 2006

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.